OSA is a heterogeneous disease with highly varying underlying mechanisms. OSA has
variable clinical manifestations with definable subsets having risk of particular …

Traditionally, the presence and severity of obstructive sleep apnea (OSA) have been defined
by the apnea–hypopnea index (AHI). Continuous positive airway pressure is generally first …

Background Therapy options for OSA and central sleep apnea (CSA) are limited, thus many
patients remain untreated. Clinically, acetazolamide is sometimes used for CSA; however …

Recent advances in obstructive sleep apnoea (OSA) pathophysiology and translational
research have opened new lines of investigation for OSA treatment and management. Key …

Rationale: Daily exposure to mild intermittent hypoxia (MIH) may elicit beneficial
cardiovascular outcomes. Objectives: To determine the effect of 15 days of MIH and in-home …

Obstructive sleep apnea is a sleep and breathing disorder, in which, patients suffer from
cycles of atonia of airway dilator muscles during sleep, resulting in airway collapse, followed …

Purpose To evaluate the prevalence, characteristics, and respiratory arousal threshold
(ArTH) of Chinese patients with positional obstructive sleep apnea (POSA) according to the …

Sleep medicine is an ambitious cross-disciplinary challenge, requiring the mutual
integration between complementary specialists in order to build a solid framework. Although …

Introduction Obstructive sleep apnea syndrome (OSAS) and asthma are two diseases with a
high epidemiological impact that may often coexist. Both diseases have underlying …

Rationale: Untreated obstructive sleep apnea (OSA) is associated with adverse outcomes in
patients with coronary artery disease (CAD). Continuous positive airway pressure (CPAP) is …